PHLI — PacificHealth Laboratories Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -112.07% | ||
| Return on Equity | -74.61% | ||
| Operating Margin | -13.9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2007 | 2008 | 2009 | 2010 | 2011 | 2012E | 2013E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 7.43 | 7.24 | 8 | 7.2 | 6.91 | n/a | n/a | 2.17% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PacificHealth Laboratories, Inc. is engaged in developing nutrition products based on research and natural ingredients. The Company collaborates with various nutritionists, biochemists and sports scientists. Its product categories include endurance, recovery, thrive and wellness. Its product collections include Accelerade 4:1, Endurox R4 4:1, Endurox Excel, Gummies, Nutragize, Accel Gel's 4:1, and 2nd Surge. Accelerade is a sports drink that contains protein in a patented 4:1 carbohydrate-protein ratio. Endurox R4, with its patented 4:1 carb-protein ratio is focused on muscle recovery. The Company's products include Endurox Excel, Healthy Joints, Daily Wellness, Anti-inflammatory, Ashwagandha, Immuno ARMOR, TurboTest, Adreno+, Mushroom X, P2Biotics, EstroCell, Accel Gel, 2nd Surge, water bottle and Nutrient Timing.
Directors
- Frederick Duffner CEO (55)
- Stephen Kuchen CFO (51)
- Robert Portman DRC (67)
- Michael Cahr IND (72)
- Lee Feldman IND
- Last Annual
- December 31st, 2011
- Last Interim
- September 30th, 2012
- Incorporated
- April 13th, 1995
- Public Since
- December 19th, 1997
- No. of Shareholders
- 97
- No. of Employees
- 8
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 20,871,772
- Address
- 100 Lanidex Plaza, Suite 120,, PARSIPPANY, 07054
- Web
- https://www.pacifichealthlabs.com/
- Phone
- +1 7327392900
- Auditors
- WeiserMazars LLP
Similar to PHLI
Adia Nutrition
Pink Sheets on Nasdaq
African Agriculture Holdings
Pink Sheets on Nasdaq
Agri-Dynamics
Pink Sheets on Nasdaq
Agristar
Pink Sheets on Nasdaq
Aifarm
Pink Sheets on Nasdaq
FAQ
As of Today at 21:31 UTC, shares in PacificHealth Laboratories are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in PacificHealth Laboratories last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the PacificHealth Laboratories share price has underperformed the S&P500 Index by -14.02% over the past year.
There is no consensus recommendation for this security.
Find out morePacificHealth Laboratories does not currently pay a dividend.
PacificHealth Laboratories does not currently pay a dividend.
PacificHealth Laboratories does not currently pay a dividend.
To buy shares in PacificHealth Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in PacificHealth Laboratories had a market capitalisation of .
Here are the trading details for PacificHealth Laboratories:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PHLI
Based on an overall assessment of its quality, value and momentum PacificHealth Laboratories is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PacificHealth Laboratories. Over the past six months, its share price has underperformed the S&P500 Index by -99.1%.
As of the last closing price of $0.00, shares in PacificHealth Laboratories were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The PacificHealth Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
PacificHealth Laboratories' management team is headed by:
- Frederick Duffner - CEO
- Stephen Kuchen - CFO
- Robert Portman - DRC
- Michael Cahr - IND
- Lee Feldman - IND